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Surgical Treatment of Portal Hypertension 
Review of Henry Ford Hospital Experience 
Joseph P. Elliott, Jr., M.D.,* Kian H. Wong, M.D.,** and Roger F. Smith, M.D.* 
Of 146 operations performed for the complications of portal hypertension in the 
Heruy Ford Hospital between 1927 and August 31, 1969, 114 were portasystemic 
shunts. Operative mortality, sequelae and long term survival were closely lelated 
to the state of the patients' liver function and the urgency of operation. 
Although the surgical treatment of 
portal hypertension includes the man-
agement of all its major complications, 
namely, bleeding esophageal varices, 
hypersplenism and ascites, exsanguina-
tion from variceal bleeding represents 
the greatest therapeutic challenge. In 
an attempt to evaluate how effective has 
been our treatment of bleeding esopha-
geal varices and to place our current 
practice in perspective, we reviewed 
the operations performed for portal 
hypertension in the Henry Ford Hospi-
tal from 1927 to August 31, 1969. 
Clinical Material and Method 
The medical record of every patient 
who had had an operation for the treat-
ment of a complication of portal hyper-
tension during this period (1927-1969) 
was studied and the information tabu-
lated. The compiled data was then sub-
jected to analysis with the assistance of 
computer sorting. 
In this series, 146 patients were 
found to have had some form of surgi-
cal therapy for portal hypertension. 
* Division I I , Department of General Sur-
gery 
'^ '^  Division of Gastroenterology, Depart-
ment of Medicine, currently with Division 
of Preventive Medicine 
There were 83 males and 63 females. 
Although ages ranged from 4.5 years 
to 73 years, 72.2% were in the fifth, 
sixth or seventh decades of life. It was 
found that among the 146 cases, there 
were 114 who had been treated by 
some type of portasystemic shunt for a 
complication of portal hypertension. As 
the major concern of our study center-
ed on patients for whom a portasys-
temic shunting operation was done to 
treat bleeding esophageal varices, we 
focused our primary attention on this 
group of 98 patients and their operative 
results, sequelae and survival experi-
ence. 
In spite of the well-known obstacles 
that are frequently encountered in trac-
ing cirrhotic patients, we were able to 
obtain a 100% complete followup on 
all cases within two months of the 
closing date of the study (August 31, 
1969). When personal examination of 
patients was not possible, letters of in-
quiry or phone calls were made to the 
involved physicians, relatives or to 
Bureaus of Vital Statistics. 
Results 
The causes of the portal hyperten-
sion, in 91.6% ofthe 146 cases treated 
surgically, consisted of Laennec's, post-
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necrotic or biliary cirrhosis (Table 1). 
The miscellaneous category included 
such diverse causes as hepatic malig-
nancy, portal vein malformation, he-
patic mucovisidosis, and pancreatitis 
with portal vein thrombosis. One pa-
tient from Puerto Rico gave a history 
of schistosomiasis. 
When all of the cases were distrib-
uted chronologically in three surgical 
therapeutic categories (Table I I ) , we 
observed that: splenectomy alone was 
used as the primary form of treatment 
before 1950 and has been rarely used 
since that time; variceal and arterial 
ligations enjoyed some popularity be-
tween 1950 and 1960; however, porta-
systemic shunts have been used with in-
creasing frequency in each period. Be-
cause portasystemic shunting opera-
tions have now become the accepted 
form of therapy in contrast to ligations 
or splenectomy, we will deal chiefly 
with the results of the 114 portasys-
temic shunts. 
The most frequently used type of 
portal vein decompression (Table I I I ) 
was a portacaval shunt (58.8%); two-
thirds being of the end-to-side variety. 
The next most frequently used type of 
shunt was a splenorenal shunt (37.7%); 
recently, there have been four cases in 
which a caval-mesenteric shunt has 
been constructed. 
Five of the 114 portasystemic shunt-
ing procedures were done before the 
advent of effective medical diuretic 
therapy in attempts to control intract-
able ascites. Two patients died post-
operatively, and in the remaining three 
TABLE I 
ETIOLOGY OF PORTAL HYPERTENSION 
ETIOLOGY 
OPERATIONS 
NO. % 
Laennec's cirrhosis 99 67.8^ 
Post-necrotic cirrhosis 29 19.7 > 91.6% 
Biliary cirrhosis 6 4.1 
Miscellaneous* 9 6.3 
No information 3 2.1 
TOTAL 146 100.0 
Note: Hepatic malignancy, hepatic mucovisidosis, 
portal vein malformation and pancreatitis 
with portal vein thrombosis - 2 cases each. 
Schistosomiasis - 1 case. 
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TABLE II 
CHRONOLOGICAL DISTRIBUTION OF TYPE OF OPERATION 
TIME PERIOD 
PORTASYSTEMIC 
SHUNTS 
VARICEAL 
AND/OR 
ARTERIAL 
SPLENECTOMY LIGATION TOTAL 
1927 - 1950 3 
1951 - 1960 37 
1961 - August, 1969 74 
10 
4 
3 
0 13 
14 55 
1 78 
TOTAL 114 17 15 146 
TABLE III 
TYPE OF PORTASYSTEMIC SHUNT 
TYPE OF SHUNT 
OPERATIONS 
NO. % 
PORTACAVAL 67 58.8 
End-to-side 48 
Side-to-slde 19 
SPLENORENAL 43 37.7 
CAVAL-MESENTERIC 4 3.5 
TOTAL 114 100.0 
Note: Emergency Operations: Portacaval 16, 
Splenorenal 2, and Caval-Mesenteric 0 
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patients the ascites was not improved. 
Fortunately, it has not been necessary 
to consider a shunting procedure for a 
case of ascites in the past eight years. 
Eleven shunting operations were per-
formed in conjunction with splenec-
tomy for hypersplenism. As would be 
expected, nine of the shunts were splen-
orenal, but in two other patients it was 
necessary, because of an inadequate 
splenic vein, to resort to portacaval 
anastomosis in one case and, in the 
other, a caval-mesentric communica-
tion. There were two operative deaths 
in this group. Six of the 11 patients 
were still alive at the end of the review 
period, with a mean survival time of 39 
months. 
The most frequent and, for the sur-
geon dealing with massive gastrointes-
tinal bleeding, the most pressing indi-
cation for a shunting procedure is 
bleeding from esophageal varices. Nine-
ty-eight of the 114 portasystemic shunts 
in this series were done for this reason. 
Operations for variceal bleeding 
were classified in two ways. First, if the 
shunt was done during a bleeding epi-
sode, the operation was classified as 
emergency; if the bleeding was first 
controlled and the shunt performed as 
a planned procedure, it was considered 
elective. Secondly, patients undergoing 
a shunting operation were classified in-
to three grades of surgical risk based 
primarily on the degree of their liver 
dysfunction, using a modification of 
the criteria recommended by Child 
and Turcotte (Table IV) . i In most 
cases, the category of risk was obvious; 
however, the poorer grade was chosen 
if two or more parameters applied. 
Since most deaths in this series at-
tributable directly to the surgical inter-
vention occurred within a few days or 
weeks of the operation, we have con-
sidered those occurring during the first 
month as an operative mortality. 
The operative mortality for shunting 
procedures undertaken for variceal 
bleeding was tabulated (Table V) ac-
cording to the type of shunt, urgency 
TABLE IV 
DEFINITION OF GRADE OF SURGICAL RISK 
GRADE I GRADE II GRADE III 
Bilirubin (mg %) 
Albumin (gm %) 
Ascites 
Encephalopathy 
Nutrition 
Associated disease 
Less than 2.0 2.0 to 3 
More than 3.5 3.0 to 3.5 
None Easily controlled 
None Minimal 
Excellent Good 
None Single or minor 
More than 3 
Less than 3.0 
Uncontrolled 
Advanced (Coma) 
Wasting 
Serious or 
multiple 
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TABLE V 
OPERATIVE MORTALITY IN 98 SHUNTS FOR VARICEAL BLEEDING 
ACCORDING TO TYPE OF SHUNT, URGENCY AND SURGICAL RISK 
<D 
O 
QL 
o 
^-• 
0) 
E 
CO 
CO 
o 
•5, 
CO 
GRADE I 
SURGICAL RISK 
GRADE II GRADE III TOTAL 
TYPE OF SHUNT OPS %MORT OPS %MORT OPS %MORT OPS %MORT 
Portacaval 
Elective 
Emergency 
Total 
19 
2 
21 
0.0% 
100.0% 
9.5% 
19 
4 
23 
15.8% 
50.0% 
21. 7% 
10 
10 
20 
30.0% 
60.0% 
45.0% 
48 
16 
64 
12.5% 
62.5% 
25.0% 
Splenorenal 
Elective 
Emergency 
Total 
10 
0 
10 
0.0% 
0.0% 
15 
1 
16 
20.0% 
0.0% 
18.8% 
4 
1 
5 
25.0% 
0.0% 
20.0% 
29 
2 
31 
13.8% 
0.0% 
12.9% 
Caval-Mesenteric 
Elective 
Emergency 
Total 
1 
0 
1 
0.0% 
0.0% 
2 
0 
2 
0.0% 
0.0% 
0 
0 
0 
3 
0 
3 
0.0% 
0.0% 
TOTAL 32 6.3% 41 19.5% 25 40.0% 98 20.4% 
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of operation and the grade of surgical 
risk. Although the number of cases in 
some categories is too small to be 
significant, certain trends can be recog-
nized. While the overall surgical mor-
tality was 20.4%, the mortality for pa-
tients undergoing shunting procedures 
with Grade I risk was 6.3%, with 
Grade I I 19.5%, and with Grade I I I 
40%. When the operative mortality of 
the 80 elective shunts for the treatment 
of bleeding varices was considered 
(Table VI), the adverse effect of the in-
creased severity of liver disease was 
again obvious; the mortality for Grade 
I was 0; for Grade I I 16.6%, and for 
Grade I I I 28.6%. The overall mortality 
for elective cases was 12.5%. This also 
clearly demonstrates the decreased 
mortality rate for elective cases in con-
trast to the emergency shunt group 
(55.5%). 
The influence of the underlying liver 
disease in determining the success of 
treatment of these patients is again 
seen when the causes of operative mor-
tality are investigated (Table VII) . The 
most frequent cause of operative mor-
tality was hepatic failure (35%). Con-
tinued variceal bleeding and/or bleed-
ing from a duodenal ulcer accounted 
for 30% of the operative mortality. 
Although in some cases determination 
was difficult, it was usually assumed 
that the cause of upper gastrointestinal 
bleeding was related to the patient's 
portal hypertension. 
In the group of 78 survivors of the 
98 shunting operations for bleeding 
esophageal varices of all grades, ob-
servations were made concerning cer-
tain postoperative sequeUae: namely, 
encephalopathy, ascites and recurrent 
upper gastromtestinal bleeding. 
An attempt was made to grade the 
degree of encephalopathy in individual 
cases. This posed a difficult problem 
both from the standpoint of evaluating 
subjective symptoms, which varied 
greatly with time, and also from the 
standpoint of the amount of occupa-
tional disability. Employment demands 
on patients were so different that de-
ficiencies could not be objectively 
classified. Many were retired in their 
protected home environment or con-
tinued to do non-demanding work, 
noting only a tendency to fall asleep 
early in the evening. In contrast, 
a trial lawyer found he was not 
alert enough to continue his occu-
pation after a portacaval shunt, even 
though to a casual observer he ap-
peared unchanged. It was found that 
about 60% of the patients noted some 
evidence of encephalopathy (Table 
VIII ) , following a portacaval shunt, 
varying from minimal to severe. There 
was no significant difference between 
the end-to-side and side-to-side ana-
stomosis in this respect. After a splen-
orenal shunt, the incidence was sig-
nificantly less. There was no encephalo-
pathy among the three patients with 
caval-mesenteric anastomoses, done 
primarily for extra-hepatic portal ob-
struction in the presence of good liver 
function. As could be expected, the 
severity of post-operative encephalo-
pathy (Table IX) varied directly with 
the grade of preoperative liver dysfunc-
tion. Seven of 30 Grade I cases surviv-
ing operation had some degree of en-
cephalopathy. Only four of these 
(13.3%) were 3-|- in severity. Over 
50% of Grade I I operative survivors 
had encephalopathy. In Grade I I I , 11 
of 15 patients, or 73%, had varying 
degrees of encephalopathy and of these, 
eight or 53.3% were 3-1-. 
126 
TABLE VI 
o 
Q. 
0 ) 
CO 
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= 
to 
OPERATIVE MORTALITY IN 80 ELECTIVE SHUNTS 
FOR VARICEAL BLEEDING 
GRADE I 
SURGICAL RISK 
GRADE II GRADE III TOTAL 
TYPE OF SHUNT OPS %MORT OPS %MORT OPS %MORT OPS %MORT 
Portacaval 19 0.0% 19 15.8% 10 30.0% 48 12.5% T—< 
Splenorenal 10 0.0% 15 20.0% 4 25.0% 29 13.8% 
Caval-Mesenteric 1 0.0% 2 0.0% - - 3 0.0% 
TOTAL 30 0.0% 36 16.6% 14 28.6% 80 12.5% 
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TABLE Vll 
CAUSE OF OPERATIVE MORTALITY 
IN 98 SHUNTS FOR VARICEAL BLEEDING 
CAUSE OF OPERATIVE DEATH 
PORTACAVAL 
NO. % 
SPLENORENAL 
NO. % 
TOTAL 
NO. 
Liver failure 
Cardiopulmonary 
Variceal bleeding 
Bleeding ulcer 
Other 
5 
4 
3 
2 
2 
31.2 
25.0 
18.8 
12.5 
12.5 
50.0 
0.0 
0.0 
25.0 
25.0 
30.0 
TOTAL 16 100.0 100.0 20 100.0 
Note: Patients with caval-mesenteric shunts had no 
operative mortality. 
TABLE VIII 
INCIDENCE OF POSTOPERATIVE ENCEPHALOPATHY IN 78 OPERATIVE 
SURVIVORS OF 98 SHUNTS FOR VARICEAL BLEEDING 
TYPE OF SHUNT 
IMMEDIATE 
SURVIVALS 
NO. CASES 
P. 0. ENCEPHALOPATHY 
NO. % 
Portacaval 
End-to-Side 
Side-to-Side 
Splenorenal 
Caval-Mesenteric 
33 
15 
27 
3 
20 
9 
6 
0 
60.6 
60.0 
22.0 
0.0 
TOTAL 78 35* 44.9 
Note: Severity of postoperative encephalopathy: 
+1-9 cases; +2f-11 cases; +3-15 cases 
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TABLE DC 
SEVERITY OF POSTOPERATIVE ENCEPHALOPATHY 
ACCORDING TO HEPATIC DYSFUNCTION 
IN 78 SURVIVORS OF 98 PORTASYSTEMIC SHUNTS 
FOR VARICEAL BLEEDING 
SEVERITY OF 
HEPATIC 
DYSFUNCTION 
IMMEDIATE 
SURVIVORS 
NO. CASES 
SEVERITY OF P. 0. 
+1 +2 
NO. NO. 
ENCEPHALOPATHY* 
+3 TOTAL 
NO. NO. 
Grade I 
Grade II 
Grade III 
30 
33 
15 
2/30 1/30 4/30 7/30 23.3 
7/33 7/33 3/33 17/33 51.5 
0/15 3/15 8/15 11/15 73.3 
Definition of the severity of encephalopathy: 
+1 = Mild transient confusion easily controlled with diet 
+2 = Transient confusion controlled by diet and non-
absorbable antimicrobial 
+3 = Confusion controlled with difficulty by diet and 
non-absorbable antimicrobial 
Ascites of varying degree occurred 
in 57.7% of the 78 post-operative sur-
vivors (Table X), which was twice the 
preoperative incidence in these patients. 
The ascites was effectively treated by 
salt-restriction and/or diuretics in 
44.6%. It was controlled with some 
difficulty in another 10.3%, but per-
sisted in 2.6% in spite of treatment. 
While there was no clear difference be-
tween the end-to-side and side-to-side 
portacaval shunts, patients with a splen-
orenal anastomosis were slightly less 
subject to postoperative ascites. 
Eleven of the 78 postoperative sur-
vivors, or 14%, had an episode of re-
current bleeding (Table XI) . The porta-
caval anastomosis restilted in a low in-
cidence of recurrent bleeding (4.2%), 
but the anatomically smaller spleno-
renal shunt resulted in a significantly 
increased occurrence (33.3%). 
Patency rates of the 98 shunts done 
for bleeding varices, whether or not the 
patients survived the operation, were 
studied in two ways. Where autopsies 
were performed, after either an opera-
tive or late death, patency was deter-
mined from the anatomical descrip-
tion. In those dead without autopsy or 
still living, patency was assiuned if 
there was no evidence of recturrent 
bleeding. When upper g^strontestinal 
bleeding occurred postoperatively, re-
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INCIDENCE OF POSTOPERATIVE ASCITES 
IN 78 OPERATIVE SURVIVORS OF 98 SHUNTS 
FOR VARICEAL BLEEDING 
TYPE OF SHUNT 
Portacaval 
End-to-side 
Side-to-side 
Splenorenal 
Caval-Mesenteric 
IMMEDIATE 
SURVIVALS 
NO. CASES 
SEVERITY OF POSTOPERATIVE ASCITES* 
+1 +2 +3 +4 
NO. NO. 
TOTAL 
% NO. % NO. % NO. 
33 
15 
27 
3 
7 21.2 11 33.3 3 9.1 1 3.0 22 66.7 
3 20.0 3 20.0 2 13.3 1 6.6 9 60.0 
14.8 7 25.9 11.1 0 0.0 14 51.9 
0 0.0 0 0.0 0 0.0 0 0.0 0 0.0 
o 
3 
TO 
SJ 
(A 
3 
TOTAL 78 14 17.9 21 26.7 8 10.3 2 2.6 45** 57.7 
* Definition of severity of ascites: 
+1 = Ascites controlled by salt restriction. 
+2 = Ascites controlled by salt restriction and diuretics. 
+3 = Ascites controlled with difficulty by salt restriction and diuretics. 
+4 = Ascites uncontrolled. 
** 22 cases had no clinical evidence of preoperative ascites. 
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TABLE XI 
INCIDENCEOF RECURRENT GASTROINTESTINAL BLEEDING 
78 OPERATIVE SURVIVORS OF 98 SHUNTS FOR VARICEAL BLEEDING 
TYPE OF SHUNT 
IMMEDIATE 
SURVIVORS 
NO. CASES 
P.O. G.I. BLEEDING 
NO. 
Portacaval 
End-to-Side 33 *1 3.0 
Side-to-Side i5. 6.7 
TOTAL 48 4.2 
Splenorenal 27 33.3 
Caval-Mesenteric 3 0 0.0 
TOTAL 78 11 14.0 
* Liver Status: Grade 1 - 1 case 
** Liver Status: Grade III - 1 case 
***Liver Status: Grade 1 - 3 cases, Grade II - 4 cases, 
Grade III 2 cases 
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current esophageal bleeding was in-
criminated unless proven otherwise. It 
was occasionally a conjecture as to 
whether the actual cause was hemor-
rhage from esophageal varices, peptic 
ulcer, or a variety of hemorrhagic dis-
orders. Using these two criteria, pat-
ency for the portacaval shunts was 
90.2% and for the splenorenal shunts 
72.2% (Table XII ) . Al l of the caval-
mesenteric shunts were patent clini-
cally (two cases), or at autopsy (one 
case). The overall patency rate was 
95.9%. 
When the causes of late death are 
analyzed, the marked influence of the 
primary liver disease is again observed 
(Table XII I ) , with liver failure causing 
over half the late deaths. 
In order to show the effect of porta-
systemic shunts on survival, a cumu-
lative survival curve for the 98 cases of 
portasystemic shunts done for bleeding 
esophageal varices was constructed ac-
cording to the method outlined in 
Szilagyi et al^ (Table 14 and Fig 1). In 
Figure 1 the survival curve is compared 
first to the expected survival of a hypo-
thetical population group with a similar 
mean age using life tables^ and, second, 
to a group of 33 nonoperative patients 
who had had one episode of bleeding 
from esophageal varices, taken from 
Baker et al.* The "normal" loss of sur-
vival in 10 years was roughly 10%, 
while the overall survival for our cases 
treated with portasystemic shunting 
shows a steady decline to 30% at seven 
and 27% at ten years. In the group of 
33 patients foUowed without surgery 
(Baker et al-*), there was no survival 
after four years. 
The effect of the degree of liver dys-
function on survival is shown by com-
paring three separate cumulative sur-
vival curves (Fig 2 and Tables XV, 
X V I , XVII) . After the fourth year, the 
curves for Grades I (32 cases) and I I 
(41 cases) are surprisingly close and 
paraUel to each other. The curves for 
Grades I , I I and I I I in Figure 2 and 
the nonoperative curve in Figure 1 
have surprisingly parallel slopes at dif-
ferent levels of survival after the first 
year. All of the curves for operative 
and nonoperative treatment, although 
parallel to each other, are considerably 
steeper than the population sample 
curve. 
Discussion 
The chronological distribution of op-
erations reflects that the surgeons in-
volved in this series have come to rely 
primarily on the proven efficacy of de-
compression of the portal system by 
a shunting procedure to treat the 
hemorrhagic complications of portal 
hypertension. This conclusion has been 
reached by others.'' 
The last time that ascites was the 
sole indication for a shunt in our series 
was in 1962. In a comparable series,^  
most of the cases of intractable ascites 
were operated upon before 1960. The 
current lack of interest in portacaval 
shunting to treat ascites has been at-
tributed to the great improvement in 
medical therapy. 
The 11 patients who had an opera-
tion for hypersplenism with an associ-
ated portasystemic shunt have had sat-
isfactory results. This indicates to us 
that when splenectomy must be done 
for portal hypertension with secondary 
hypersplenism, a concomitant shunting 
procedure, preferably a splenorenal 
shunt, should be done at the same time, 
even if there are no actively bleeding 
esophageal varices. In this respect, we 
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TABLE XII 
DETERMINATION OF SHUNT PATENCY 
BY AUTOPSY OR CLINICAL EVALUATION 
o 
I 
1 
s. 
4 ) 
B 
CO 
£? 
TYPE OF SHUNT 
Portacaval 
End-to-Side 
Side-to-Side 
Total 
Splenorenal 
Caval-Mesenteric 
TOTAL 
AUTOPSIED CLINICAL EVALUATION* 
NO. 
AUTOPSIED % PATENT 
NO. WITHOUT 
AUTOPSY % PATENT 
TOTAL 
14 
_4 
18 
15 
1 
34 
78.6 
100.0 
83.3 
80.0 
100.0 
82.4 
32 
M 
46 
16 
2 
64 
90.6 
100.0 
93.5 
68.8 
100.0 
Note: Patency assumed if no recurrent bleeding. 
96.9 
NO. OF 
OPS. 
46 
64 
31 
3 
98 
% PATENT 
87.0 
100.0 
90.2 
72.2 
100.0 
95.9 
t o 
TABLE XIII 
CAUSE OF LATE MORTALITY 
IN 98 SHUNTS FOR VARICEAL BLEEDING 
PORTACAVAL SPLENORENAL CAVAL-MESENT. TOTAL 
CAUSE OF NO. % NO. % NO. % NO. % 
LATE DEATH DEATHS DEATHS DEATHS DEATHS DEATHS DEATHS DEATHS DEATHS 
Liver failure 16 69.7 7 38.9 0 0.0 23 54.8 
Variceal bleeding 1 4.3 4 22.2 0 0.0 5 11.9 
Bleeding ulcer 1 4.3 1 5.6 0 0.0 2 4.8 
Cardiopulmonary 3 13.0 2 11.1 0 0.0 5 11.9 
Other 2 8.7 4 22.2 1 100.0 7 16.6 
TOTAL DEATHS 23 100.0 18 100.0 1 100.0 42 100.0 
o 
3 
013 
a) 
CO 
3 
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TABLE XIV 
CUMULATIVE 20 YEAR SURVIVAL OF 98 CASES OF PORTAL HYPERTENSION 
WITH VARICEAL BLEEDING TREATED BY PORTASYSTEMIC SHUNTS (Includes Grade I - 32 Cases, Grade II - 41 Cases, Grade III - 25 Cases) 
PERIOD OF 
FOLLOW UP 
PATIENTS FOLLOWED 
FOR INDICATED 
PERIOD 
SURVIVORS FOR 
INDICATED 
PERIOD 
SURVIVAL RATE 
1 month 98 80 81.6 
3 months 97 74 76.3 
6 months 95 67 70.5 
1 year 93 59 63.4 
2 years 93 57 61.3 
3 years 84 44 52.3 
4 years 78 38 48.7 
5 years 68 28 41.2 
6 years 5C 20 33.3 
7 years 54 16 29.6 
8 years 50 15 30.0 
9 years 40 12 30.0 
10 years 33 9 27.3 
11 years 29 5 17.2 
12 years 22 3 13.6 
13 years 20 1 5.0 
14 years 16 1 6.3 
15 years 11 0 0.0 
16 years 10 0 0.0 
17 years 6 0 0.0 
18 years 5 0 0.0 
19 years 2 0 0.0 
20 years 1 0 0.0 
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100 
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POPULATION SAMPLE 
9 8 PORTASYSTEMIC SHUNTS 
GRADE 1 - 3 2 CASES 
GRADE i r - 4 1 CASES 
GRADE I I I - 2 5 CASES 
- 3 3 NONOPERATIVE CASES 
after 1st hemorrhage 
(Baker et al 
Ii 2 3 4 5 6 7 8 9 10 
LENGTH of SURVIVAL ( Y E A R S ) 
Figure 1 
Graphic representation of the cumulative survival experience'of our 98 cases of portal hyper-
tension with esophageal bleeding treated by portasystemic shunts (Table XIV) compared to 
the calculated survival of a hypothetical general population sample with the same mean age"-
and to the previously published survival experience of 33 nonoperatvie cases after a first hemor-
rhage from esophageal varices (Baker et al^). 
do "prophylactic shunts" in good risk 
padents with portal hypertension and 
hypersplenism, as has also been recom-
mended by Drapanus." We have not, 
however, undertaken prophylactic op-
erations to prevent variceal bleeding in 
the presence of esophageal varices that 
have been entirely asymptomatic. Nor 
are we encouraged to do so from the 
controlled survival figures compiled by 
Jackson et al^ or Garceau et al.^ 
Because of the favorable mortality 
experience with elective shunting pro-
cedures, compared to emergency oper-
ations (Table V), our current plan of 
treatment is to use double balloon tam-
ponade for the initial control of esopha-
geal bleeding. This maneuver also aids 
in diagnosis as to the source of the 
hemorrhage; whether variceal or peptic 
ulcer. Following evaluation, a program 
is instituted to improve the patient's 
liver function and category of surgical 
risk for an elective operation that is 
ideally scheduled within a few days or 
weeks. Those patients who continue to 
bleed in spite of esophageal tamponade 
or who rebleed after its use for 24 to 
48 hours may require an emergency 
operation in spite of the high risk in-
volved. 
Operative mortality (Table V) was 
adversely affected by poor liver status. 
Similarly, Hermann et aP fotmd a mor-
tality of 17% for good hepatic surgical 
risks and 48% for those patients with 
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poor hepatic function. In the same 
series, emergency operative mortality 
was 7 1 % , while the elective mortality 
was 16%. Although the patients in 
Hermann's series and our series are not 
truly comparable, the figures in Tables 
V and V I also indicate the importance 
of trying to perform shunts only elec-
tively. Grace" has further emphasized 
this. In an extensive review of the lit-
erature, he found that the overall emer-
gency operative mortality was 31.8%, 
while elective mortality was 15.5%. 
In view of the almost prohibitive 
mortality (55.6%) for patients under-
going an emergency operation and 
classified as Grade I I I surgical risk, we 
feel that alternative types of treatment 
are justified in patients with poor liver 
function and should be thoroughly in-
vestigated. Selective superior mesen-
teric arterial infusion with pitressin^'' or 
portal vein decompression via the um-
bilical and saphenous vein^^ deserve 
consideration in selected cases. 
Grace" found an incidence of post-
operative encephalopathy of 22.2% for 
portacaval shunts and 13.4% for splen-
orenal shunts. In our series, we found 
a higher incidence: 60% in the porta-
caval and 22% in the splenorenal 
group. The symptoms in our cases 
varied from mild, transient episodes of 
dullness, sleepiness or confusion to 
those severe enough to require diet and 
medication for control. The disparity in 
the reported figures for the postopera-
tive incidence of encephalopathy may 
be partly due to the variable definition 
of significant encephalopathy. 
3 4 5 6 7 8 9 10 
LENGTH of SURVIVAL (YEARS) 
12 13 14 15 
Figure 2 
Cumulative survival curves for 32 Grade I cases, 41 Grade I I cases and 25 Grade I I I cases, 
treated by portasystemic shunting for variceal bleeding (Tables XV, XVI and XVII). 
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TABLE XV 
CUMULATIVE 20 YEAR SURVIVAL OF 32 GRADE I CASES 
OF PORTAL HYPERTENSION WITH VARICEAL BLEEDING 
TREATED BY PORTASYSTEMIC SHUNT 
PERIOD OF 
FOLLOW UP PATIENTS FOLLOWED FOR INDICATED 
PERIOD 
SURVIVORS FOR 
INDICATED 
PERIOD 
SURVIVAL RATE 
FOR INDICATED 
PERIOD (%) 
1 month 32 30 93.8 
3 months 32 30 93.8 
6 months 31 29 93.5 
1 year 31 26 83.9 
2 years 31 26 83.9 
3 years 27 18 66.7 
4 years 25 15 60.0 
5 years 24 13 54.2 
6 years 23 10 43.5 
7 years 22 9 40.9 
8 years 21 9 42.9 
9 years 19 7 36.8 
10 years 15 6 40.0 
11 years 14 4 28.6 
12 years 11 3 27.3 
13 years 9 1 11.0 
14 years 6 1 16.7 
15 years 4 0 0.0 
16 years 4 0 0.0 
17 years 3 0 0.0 
18 years 3 0 0.0 
19 years 2 0 0.0 
20 years 1 0 0.0 
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TABLE XVI 
CUMULATIVE 20 YEAR SURVIVAL OF 41 GRADE II CASES 
OF PORTAL HYPERTENSION WITH VARICEAL BLEEDING 
TREATED BY PORTASYSTEMIC SHUNT 
PERIODOF 
FOLLOW UP 
PATIENTS FOLLOWED 
FOR INDICATED 
PERIOD 
SURVIVORS FOR 
INDICATED 
PERIOD 
SURVIVAL RATE 
FOR INDICATED 
PERIOD (%) 
1 month 41 34 82.9 
3 months 40 31 77.5 
6 months 38 27 71.1 
1 year 38 26 68.4 
2 years 38 25 65.8 
3 years 35 21 60.0 
4 years 33 20 60.6 
5 years 27 14 51.9 
6 years 22 10 45.5 
7 years 19 7 36.8 
8 years 17 6 35.3 
9 years 14 5 35.7 
10 years 12 3 25.0 
11 years 11 1 9.1 
12 years 9 0 0.0 
13 years 9 0 0.0 
14 years 8 0 0.0 
15 years 5 0 0.0 
16 years 4 0 0.0 
17 years 2 0 0.0 
18 years 1 0 0.0 
19 years 0 0 0.0 
20 years 0 0 0.0 
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TABLE XVII 
CUMULATIVE 20 YEAR SURVIVAL OF 25 GRADE III CASES 
OF PORTAL HYPERTENSION WITH VARICEAL BLEEDING 
TREATED BY PORTASYSTEMIC SHUNT 
PERIOD OF 
FOLLOW UP 
PATIENTS FOLLOWED 
FOR INDICATED 
PERIOD 
SURVIVORS FOR 
INDICATED 
PERIOD 
SURVIVAL RATE 
FOR INDICATED 
PERIOD (%) 
1 month 25 16 64.0 
2 months 25 13 52.0 
3 months 24 9 37.5 
1 year 24 7 29.2 
2 years 24 7 29.2 
3 years 22 5 22.7 
4 years 20 3 15.0 
5 years 17 1 5.9 
6 years 15 0 0.0 
7 years 13 0 0.0 
8 years 12 0 0.0 
9 years 7 0 0.0 
10 years 6 0 0.0 
11 years 4 0 0.0 
12 years 2 0 0.0 
13 years 2 0 0.0 
14 years 2 0 0.0 
15 years 2 0 0.0 
16 years 2 0 0.0 
17 years 1 0 0.0 
18 years 1 0 0.0 
19 years 0 0 0.0 
20 years 0 0 0.0 
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The incidence of postoperative 
bleeding (Table XI) compares well with 
another reported series. Sedgwick^-
found an 8% and a 17% incidence for 
end-to-side and side-to-side portacaval 
shunts, respectively, and a 26.5% in-
cidence of recurrent bleeding for 
splenorenal shunts. It would appear 
that the splenorenal shunt offers less 
protection from recurrent bleeding than 
the portacaval shunt. 
The loss of life from operative and 
late postoperative mortality (Tables 
V I I and XII I ) is closely related to 
hepatic dysfunction. The effect of the 
degree of liver impairment on cumula-
tive survival experience following por-
tasystemic shunting can also be seen 
in Figure 2. For obvious practical clini-
cal reasons we have no "control pa-
tients" from our own experience. We 
have, therefore, compared our survival 
results with a group of 33 patients fol-
lowed by Baker et al* who did not un-
dergo surgical treatment after one epi-
sode of bleeding from proven esopha-
geal varices. When the survival curve 
of these medically-treated patients is 
plotted (Fig 1), it falls well below the 
curves for our surgically-treated Grade 
I and Grade I I patients, and somewhat 
below the curve for patients in the 
Grade I I I risk group (Fig 2). Thus, 
even if all of the cases in Baker's series 
were considered to be in the Grade I I I 
group, there seems to be some advan-
tage to the surgical approach for even 
the poor risk patient. 
Summary and Conclusions 
In the Henry Ford Hospital between 
1927 and August 31, 1969, 146 opera-
tions were performed for the treatment 
of the complications of portal hyper-
tension. Of this group, 114 were porta-
systemic shunts; five for ascites, 11 for 
hypersplenism and 98 for bleeding eso-
phageal varices. 
A survey of these cases has led to 
the following conclusions: 
1. Ascites associated with liver cir-
rhosis and portal hypertension is best 
treated medically. 
2. Patients who are reasonable 
risks requiring splenectomy for sec-
ondary hypersplenism with associated 
portal hypertension and esophageal 
varices should have concomitant 
splenorenal shunt if technically possi-
ble. This is the only type of prophylac-
tic portasystemic shunt that is recom-
mended where there is no history of 
bleeding esophageal varices. 
3. In patients who have portasys-
temic shunts performed for bleeding 
esophageal varices, the operative mor-
tality and long-term survival depends 
primarily upon their state of liver func-
tion and the urgency of the operation. 
a. In Grade I cases, an elective 
shunt can be offered with good as-
surance of satisfactory result. 
b. In Grade I I I patients, an 
emergency shunt should be avoided 
if at all possible because of an ac-
companying mortality rate of over 
50%. 
c. Those patients classified in 
Grade I I require a high degree of 
medical and surgical judgment be-
fore an operation is recommended. 
A vigorous attempt should be made 
to convert these patients into candi-
dates for elective rather than emer-
gency operations and to bring their 
liver function to its optimal state 
prior to any operative intervention. 
4. Portacaval shunts (compared to 
splenorenal shunts) offer greater like-
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lihood of continued patency and pro- whose occupations require a high de-
tection from recurrent bleeding. How- gree of intellectual activity, 
ever, caution must be exercised in the 5. Caval-mesenteric shunt is excel-
use of portacaval shunts, in patients lent in children and selected adults. 
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